This overview has been developed for program planners considering introduction and/or expansion of the use of oxytocin, and in particular oxytocin packaged in the Uniject™ device, to reduce the incidence of postpartum hemorrhage as a component of their maternal and child health programming. Administering oxytocin is just one component of active management of third stage labor.
Corporate author(s): PATH
Published: September 2008
Region: Global
Available materials
Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers
133 KB PDF
Hard copies are not available.
Introducing Oxytocin in the Uniject™ Device: An Overview for Decision-Makers
131 KB PDF
Also known as: Introducción de Oxitocina en el Dispositivo Uniject™: Una Visión General Para Tomadores de Decisiones
Hard copies are not available.
English
Spanish
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
See also:
For more information…
Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH Publications, 1455 NW Leary Way, Seattle WA 98107